Various polymers are conventionally made using diepoxide reactants reacted with extender compounds to build molecular weight. For example, epoxy polymers made by reacting bisphenol A (“BPA”) with the diglycidyl ether of BPA (“BADGE”) are used in a variety of polymer end use applications, including in coating compositions for use in preventing or inhibiting the corrosion of metals.
The present invention provides a liquid epoxy resin composition that is preferably useful in making a polymer such as an aromatic polyether polymer. In some embodiments, such polymers are useful for formulating food or beverage container coatings, including food-contact food or beverage container coatings. The liquid epoxy resin composition is preferably storage stable under ambient conditions for at least 1 month, more preferably for at least 3 months, and even more preferably for at least 6 months or even a year or more. In preferred embodiments, the liquid epoxy resin composition is preferably substantially free, more preferably completely free, of materials having estrogenic activity greater or equal to that of bisphenol S (“BPS”).
In one embodiment, a liquid epoxy resin composition is provided that is preferably substantially free of bisphenol A (“BPA”), bisphenol F (“BPF”), and BPS, including any epoxides thereof, and is derived from reactants including an epihalohydrin (more preferably epichlorohydrin) and a diphenol (more preferably a substituted diphenol, and even more preferably an ortho-substituted diphenol). The liquid epoxy resin composition preferably comprises less than 80 weight percent, if any, of n=0 diepoxide compounds derived from a diphenol, based on the total weight of any unreacted diphenol and any compounds including at least one structural unit derived from a diphenol.
In another embodiment, a liquid epoxy resin composition is provided that is preferably substantially free of BPA, BPF, BPS, including any epoxides thereof, and is derived from reactants including epichlorohydrin and tetramethyl bisphenol F (“TMBPF”). The liquid epoxy resin composition preferably comprises at least 85 weight percent of n=0 and n=1 TMBPF-containing diepoxide resins, based on the total weight of any compounds present including at least one structural unit derived from TMBPF and any unreacted TMBPF that may be present. The liquid epoxy resin composition also preferably includes less than 80 weight percent of n=0 TMBPF-containing diepoxide resins, based on the total weight of compounds present including at least one structural unit derived from TMBPF and any unreacted TMBPF that may be present. Preferably, liquid epoxy resin composition includes less than 5 weight percent, if any, of TMBPF-containing mono-epoxide resins.
In yet another embodiment, a polyether polymer is provided that is a reaction product of ingredients including the liquid epoxy resin composition of the present invention. In a preferred such embodiment, the polyether polymer is an aromatic polyether polymer preferably having a number average molecular weight (Mn) of at least 2,000, or at least 4,000 and a glass transition temperature (Tg) of at least 60° C., or at least 70° C.
In yet another embodiment, a process is provided that includes reacting an epihalohydrin (preferably epichlorohydrin) and a diphenol (preferably a substituted diphenol, more preferably an ortho-substituted diphenol, and even more preferably tetramethyl bisphenol F) in a molar ratio (epichlorohydrin:diphenol) of from about 7:1 to about 1:1, more preferably from about 6:1 to about 1.01:1, and even more preferably from about 5:1 to about 3:1 to provide a liquid epoxy resin composition of the present invention.
The above summary of the present invention is not intended to describe each disclosed embodiment or every implementation of the present invention. The description that follows more particularly exemplifies illustrative embodiments. In several places throughout the application, guidance is provided through lists of examples, which can be used in various combinations. In each instance, the recited list serves only as a representative group and should not be interpreted as an exclusive list.
The details of one or more embodiments of the invention are set for in the description below. Other features, objects, and advantages of the invention will be apparent from the description and from the claims.
Unless otherwise specified, the following terms as used herein have the meanings as provided below.
The term “substantially free” of a particular compound means that the compositions of the present invention contain less than 1,000 parts per million (ppm) of the recited compound. The term “essentially free” of a particular compound means that the compositions of the present invention contain less than 100 parts per million (ppm) of the recited compound. The term “completely free” of a particular compound means that the compositions of the present invention contain less than 20 parts per billion (ppb) of the recited compound. In the context of the aforementioned phrases, the compositions of the present invention contain less than the aforementioned amount of the compound whether the compound itself is present in unreacted form or has been reacted with one or more other materials.
Unless otherwise indicated, the term “polymer” includes both homopolymers and copolymers (i.e., polymers of two or more different monomers).
The term “comprises” and variations thereof do not have a limiting meaning where these terms appear in the description and claims.
The terms “preferred” and “preferably” refer to embodiments of the invention that may afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
As used herein, “a,” “an,” “the,” “at least one,” and “one or more” are used interchangeably. Thus, for example, a coating composition that comprises “an” additive can be interpreted to mean that the coating composition includes “one or more” additives.
Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, etc.). Furthermore, disclosure of a range includes disclosure of all subranges included within the broader range (e.g., 1 to 5 discloses 1 to 4, 1.5 to 4.5, 1 to 2, etc.).
The present invention pertains to epoxy resin compositions that are preferably present in liquid form at ambient conditions. In preferred embodiments, the liquid epoxy resin compositions are storage stable under ambient conditions for extended periods of time without the need for any special precautions. For example, preferred liquid epoxy resin compositions of the present invention are storage stable for at least 1 month, more preferably at least 3 months, and even more preferably at least 6 months or at least 1 year, when stored under ambient conditions (e.g., atmospheric pressure and ambient temperature such as, for example, about 15-25° C.).
During the course of the aforementioned storage periods in ambient environments, preferred storage stable epoxy resin compositions remain a homogenous liquid that is appreciably free of crystalline epoxy resin, and which can be used to make a polyether polymer without the need for any special process steps to return the sample to a usable liquid form and/or appreciably non-crystalline form. The presence of more than a trace amount of eye-visible crystals in the liquid epoxy resin composition is indicative of a composition that is not storage stable. Similarly, a composition that is a “solid” or for which a viscosity cannot be measured (e.g., using a Brookfield thermocel) is not storage stable. By way of example, a liquid epoxy resin that is clear (e.g., is free of any haze visible to the unaided human eye) and does not include suspended crystals visible to the unaided human eye is appreciably free of crystalline epoxy resin. Such a liquid epoxy resin may contain a small amount of crystals located at interfaces (e.g., an interface between the liquid and the surface of the storage vessel) and still be considered appreciably free of crystalline epoxy resin. The liquid epoxy resin compositions described herein typically do not constitute a pure sample of a particular type of diepoxide resin, but rather a mixture of two or more different diepoxide resins (and, in some embodiments, three or more different diepoxide resins, or even four or more different diepoxide resins). In addition, amounts of mono-epoxide compounds, unreacted starting compounds, reaction intermediates, and/or reaction byproducts may also be present provided the presence of such compounds does not unsuitably interfere with either: (i) the storage stability of the liquid epoxy resin composition in ambient environments or (ii) the preparation of polyether polymers from the liquid epoxy resin composition.
The liquid epoxy resin composition can be prepared by reacting one or more epihalohydrins with one or more diphenol compounds, more typically one or more substituted diphenols, even more typically one or more ortho-substituted diphenols, and even more typically one or more ortho-substituted bisphenols. Typically, all, or substantially all, of the epoxy resin present in the liquid coating composition will be derived from diphenols, more typically ortho-substituted diphenols. If desired, mixtures of different diphenol compounds may be employed, although in presently preferred embodiments a single type of diphenol is used. Moreover, although not presently preferred, it is contemplated that some epoxy resin (e.g., mono-epoxide resins and/or polyepoxide resins) may optionally be present that is not derived from a diphenol—such as, e.g., one or more aliphatic epoxy resins (e.g., epoxides derived from aliphatic materials such as aliphatic diols or diacids).
Suitable epihalohydrins that can be used herein include those represented by the following formula:
wherein R is hydrogen or a hydrocarbyl group having from 1 to about 4 carbon atoms and X is a halogen, preferably chlorine or bromine. Epichlorohydrin is a preferred epihalohydrin for use in the present invention.
Throughout this disclosure, diepoxide resins (sometimes referred to as “diepoxides” for brevity) are discussed in the context of diepoxides that are n=0, n=1, n=2, n=3, and so on. In this context, the integer value of “n” refers to the additional structural units (beyond the base structural unit derived from a diphenol), if any, present in the diepoxide that are derived from a diphenol. To further illustrate these concepts, the diglycidyl ether of tetramethyl bisphenol F produced via reaction of epichlorohydrin with tetramethyl bisphenol F (“TMBPF”), in which n is an integer value such as 0, 1, 2, or 3 or more, is shown below.
Thus, as can be seen from the above structural representation, when n is 0, a single structural unit derived from TMBPF is present, whereas when n is 1, two such structural units are present; when n is 2, three such structural units are present; when n is 3, four such structural units are present; and so on. As shown above, when two or more structural units derived from a diphenol are present, the structural units are typically attached to one another via a —CH2—CH(OH)—CH2— segment. In certain instances, the attachment may alternatively be a —CH2—CH2—CH(OH)— segment.
When n is 1 or more, the diepoxide will typically have structural units that are derived from the same type of diphenol compound. Nonetheless, it is contemplated that a given diepoxide may have structural units derived from two or more different diphenol compounds. For example, for an n=1 diepoxide, one structural unit may be derived from a first diphenol (e.g., an ortho-substituted bisphenol such as, e.g., TMBPF) and another structural unit may be derived from a second diphenol having a different chemical structure (e.g., an ortho-substituted diphenol having a single phenylene group such as, e.g., 2,5-di-tert-butyl hydroquinone).
In particular, it has been discovered that for certain diphenols (e.g., certain ortho-substituted diphenols), the amount of n=0 diepoxide resin present in the composition can affect the storage stability of the composition and/or whether the composition is a liquid at ambient conditions. In particular, it is believed that if the amount of n=0 diepoxide resin is too high, it can lead to excessive crystallinity and, in turn, insufficient storage stability at ambient conditions (and even elevated temperature conditions). For example, in generating a diepoxide resin composition using epichlorohydrin and TMBPF, it was found that when the epoxide resin composition was greater than 85% n=0 diepoxide, the resulting composition could only be stored for a couple of days, at most, at ambient conditions before excessive crystallinity resulted that would require special process steps before being usable as a reactant in a commercial resin reactor for polyether polymer production. Such additional process steps are disadvantageous because such steps can increase manufacturing complexity, slow cycle time, and/or result in other additional manufacturing costs (e.g., additional energy costs associated with high temperature process steps aimed at avoiding and/or reducing the crystallinity issue during storage and/or prior to polymer manufacture).
Thus, the amount of n=0 diepoxide resin present in the epoxy resin composition is preferably controlled so that it is sufficiently low to yield a storage stable liquid composition that is useful for making high quality polyether polymers. A useful expression for assessing the pertinent amount of n=0 diepoxide resin present in the liquid epoxy resin composition is the weight ratio (or percentage) of: (i) n=0 diepoxide resin derived from a diphenol relative to (ii) the total weight of any compounds present in the liquid epoxy resin composition that include at least one structural unit derived from a diphenol and any residual diphenol that may be present. Thus, for example, if the following compounds derived from a diphenol are present in the indicated weight part amounts in the liquid epoxy resin composition, then the pertinent n=0 diepoxide amount is 75 weight percent (wt-%):
Unless specifically defined otherwise, the % n=0, n=1, n=2, and n=3 (and so on) diepoxide should be interpreted pursuant to the weight percent expression described in the preceding paragraph.
An example of a suitable approach for assessing the amount of each of the different “n” diepoxide resins that may be present in the liquid epoxy resin composition is the HPLC method described in the below Test Methods section.
The liquid epoxy resin composition preferably includes less than about 80 wt-%, if any, of n=0 diepoxide resin, more preferably less than about 75 wt-% or less than about 70 wt-%. Typically, the composition will include at least about 50 wt-%, preferably more than 60 wt-%, even more preferably more than 65 wt-%, and in some instances more than 70 wt-% of n=0 diepoxide resin.
While not intending to be bound by any theory, it is believed it is advantageous to include more than 50 wt-%, and more preferably more than 60 wt-% of n=0 diepoxide resin to avoid the viscosity of the liquid epoxy resin composition being unsuitably high.
The liquid epoxy resin composition typically includes more than 5 wt-% of n=1 diepoxide resin. Preferably, the composition includes at least 10 wt-% of n=1 diepoxide resin, more preferably at least 15 wt-% or at least 20 wt-% of n=1 diepoxide resin. While the top end amount of n=1 diepoxide resin present in the composition is not restricted, typically the composition will include less than about 25 wt-% of such compounds, and in some instances less than about 20 wt-% of such compounds.
In preferred embodiments, the n=0 and n=1 diepoxide resins are present in the liquid epoxy resin composition in a sufficiently high amount such that the combined n=0 and n=1 weight percent is at least 80 wt-%, more preferably at least 85 wt-%, and even more preferably at least 95 wt-%. Although it is contemplated that some epoxide compounds that are not derived from a diphenol (e.g., aliphatic diepoxides derived from materials such as, e.g., cyclohexane dimethanol or tetramethyl cyclobutanediol) may be included in the liquid epoxy resin composition, typically all or substantially all of the epoxide material present (other than any residual unreacted epihalohydrin) is derived from a diphenol.
The amount of n≥2 diepoxide resin (e.g., n=2 and n=3 diepoxide resin) is preferably also controlled to provide a liquid epoxy resin composition having the balance of desired properties. While not intending to be bound by theory, it is believed that the presence of too much n≥2 epoxide resins can contribute to the epoxy composition lacking suitable storage stability and may even cause the epoxy resin composition to be a solid at ambient conditions. Thus, the amount of n≥2 epoxide resins, if any such resin(s) are present, is preferably controlled to avoid such problems.
A table is provided below offering guidance on the amount of certain components, if any, that may be present in preferred liquid epoxy compositions of the present disclosure. The below disclosure is intended as a disclosure for both (i) each component concentration threshold separately and (ii) any possible combination of component concentration thresholds.
The liquid epoxy resin composition may have any suitable viscosity. In preferred embodiments, the liquid epoxy resin composition has a viscosity at 52° C. of less than 10,000 centiPoise (cP), preferably less than 5,000 cP, and even more preferably less than 2,000 cP. An example of a suitable viscosity measuring apparatus is a Brookfield thermocel equipped with a suitable spindle and the revolutions per minute adjusted to take up most of the measuring scale for the apparatus. In presently preferred embodiments, the liquid epoxy resin has a viscosity falling with one or all of the aforementioned ranges after storage for an extended period under ambient conditions (e.g., after storage under ambient conditions for at least one month, more preferably after storage under ambient conditions for a least 6 months or 1 year or more).
Weight per epoxide equivalent is another measure that may be useful for assessing the relative amounts of the various “n” epoxy resins that may be present in the liquid epoxy resin composition. For example, while not intending to be bound by any theory, it is believed that it is desirable that the final weight per epoxide equivalent of the liquid epoxy resin composition be within about 10% to about 20% of the theoretical weight per epoxide equivalent for the n=0 diepoxide resin, more preferably within about 13% to about 17%. If more than one diphenol is used and the diphenols have different molecular weights, then the above percentages would be interpreted in the context of an average value factoring the ratio of the particular diphenol reactants employed and their corresponding n=0 diepoxide resins. In embodiments in which TMBPF is the sole diphenol used, the weight per epoxide equivalent of the liquid epoxy resin composition is preferably about 200 to about 220 grams/epoxy equivalents, more preferably about 208 to about 218 grams/epoxy equivalents.
As previously discussed, in preferred embodiments, a substituted diphenol is used to form the liquid epoxy resin composition, more typically an ortho-substituted diphenol, and even more typically an ortho-substituted bisphenol. Organic groups are preferred substituent groups, with alkyl groups being preferred, and methyl groups in particular being preferred ortho-substituent groups. In some embodiments, two aromatic rings of the bisphenol having a hydroxyl group attached thereto are connected to each other via a —CH2— linking group.
Preferred ortho-substituted diphenols for use in forming the liquid epoxy resin composition of the present invention have the below structure:
wherein:
Preferably, at least one R1 on each depicted phenylene ring is located at an ortho position on the ring relative to the hydroxyl group. In certain preferred embodiments, v is 2 to 4, more preferably 2, and an R1 is located at each ortho position on the ring relative to the hydroxyl group. Methyl groups are presently preferred ortho R1 groups. Other suitable ortho R1 groups may include ethyl, propyl, propyl, butyl, and isomers thereof (e.g., t-butyl).
A preferred ortho-substituted diphenol in which t is 1 (i.e., a bisphenol) is provided below, which is commonly referred to as tetramethyl bisphenol F.
Typically, the diphenol will be a bisphenol, although it is contemplated that diphenols in which t is 0 may also be used. An example of an ortho-substituted diphenol in which t is 0 is provided below, which is commonly referred to as 2,5-di-t-butyl hydroquinone.
It is contemplated that any of the diphenol compounds described in U.S. Pub. Nos. 2013/0206756 or 2015/0021323 may be used, with diphenol compounds that are appreciably non-estrogenic being particularly preferred. In preferred embodiments, the liquid epoxy resin composition does not include any structural units derived from bisphenol A (“BPA”), bisphenol F (“BPF”), bisphenol S (“BPS”), or any diepoxides thereof (e.g., diglycidyl ethers thereof such as the diglycidyl ether of BPA (“BADGE”)). In addition, the liquid epoxy resin composition preferably does not include any structural units derived from a dihydric phenol, or other polyhydric phenol, having estrogenic agonist activity greater than or equal to that of 4,4′-(propane-2,2-diyl)diphenol. More preferably, the liquid epoxy resin composition does not include any structural units derived from a dihydric phenol, or other polyhydric phenol, having estrogenic agonist activity greater than or equal to that of BPS. Even more preferably, the liquid epoxy resin composition does not include any structural units derived from a dihydric phenol, or other polyhydric phenol, having estrogenic agonist activity greater than 4,4′-(propane-2,2-diyl)bis(2,6-dibromophenol). Optimally, the liquid epoxy resin composition does not include any structural units derived from a dihydric phenol, or other polyhydric phenol, having estrogenic agonist activity greater than 2,2-bis(4-hydroxyphenyl)propanoic acid. In such preferred embodiments, the liquid epoxy resin composition is also preferably free of such unreacted bisphenol monomers having the properties described above. A useful method for assessing the estrogenic agonist activity (e.g., whether a diphenol is appreciably non-estrogenic) is the MCF-7 assay described in U.S. Pub. No. 2013/0206756.
If desired, one or more diluents or other materials may be present in the liquid epoxide resin composition. For example, organic solvent may be included in the liquid epoxide resin composition. The amount and identity of such diluents or other materials are preferably controlled to avoid unsuitably interfering with downstream polymerization reactions that may be used to form a polymer from reactants including the liquid diepoxide resin composition.
In some embodiments, the liquid epoxy resin composition constitutes at least 90% by weight of diepoxide resin, more preferably at least 93% by weight of diepoxide resin, and even more preferably at least 96% by weight of diepoxide resin, based on the total weight of the liquid epoxy resin composition.
The meaning of the term “liquid” in the context of an epoxy resin composition at ambient conditions should be readily understood by those of ordinary skill in the pertinent art. However, to further illustrate the meaning of the term “liquid” in this context, a non-limiting example follows. For convenience, the test method described below will be referred to hereinafter as the “Pour Test.” 50 grams of an epoxy resin composition to be assessed is weighed into a standard 100 milliliter glass beaker (e.g., a cylindrical 100 milliliter Pyrex beaker having vertical side walls about 6.5 centimeters in height) under ambient conditions (e.g., atmospheric pressure and a temperature of 22° C.). The filled beaker is turned upside down such that it is vertical and positioned immediately above a receiving vessel. Preferably, the liquid epoxy resin composition has begun flowing out of the initial beaker (e.g., beyond its outer rim) within 180 minutes or less after being turned upside down, and more preferably substantially sooner (e.g., 120 minutes or less, 60 minutes or less, 30 minutes or less, 15 minutes or less, 10 minutes or less, etc.). Epoxy resin compositions that have not begun flowing out within 180 minutes are less preferred due to difficulties associated with handling and using to form a polymer suitable for use in formulating preferred coating compositions described herein.
Any suitable method may be used to prepare a liquid epoxy resin composition having the desired population of “n” diepoxide resins described herein. Such methods may even include, for example, conversion processes (e.g., selective filtration, etc.) capable of taking an “out-of-specification” epoxy resin composition and converting it into an “in-specification” liquid epoxy resin composition. Due to the potential costs associated with such conversions, the inventors have found it convenient to use a synthesis process tailored to yield a liquid epoxy resin composition that is “in specification.” A representative such synthesis process is described in the following discussion and exemplified in the Examples section, although it is contemplated that other suitable processes may also be used.
In forming the liquid epoxy resin composition, the epihalohydrin (which is preferably epichlorohydrin) is preferably used in a stoichiometric excess relative to the diphenol, although the amount of the excess is preferably controlled to keep the n=0 diepoxides below about 80 wt-%. While not intending to be bound by theory, it is believed that if the amount of excess epihalohydrin is too high, it can result in the presence of an excessive amount of n=0 diepoxide, which can lead to excessive crystallinity and even solidification, thereby making it necessary to employ special (and more costly) measures to enable manufacture of polyether polymer from the diepoxide. For example, it was discovered that if epichlorohydrin is used in a very large stoichiometric excess relative to the diphenol in making an epoxy resin composition from epichlorohydrin and TMBPF, the resulting liquid resin composition is greater than 85% n=0 diepoxide resin and the resulting liquid composition is not storage stable beyond a couple days, at most, due to crystallinity issues.
In the non-limiting, representative synthesis process disclosed herein, the epihalohydrin(s) and the diphenol compound(s) are preferably employed in a molar ratio of from about 7:1 to about 1:1, more preferably from about 6:1 to about 1.01:1, and even more preferably from about 5:1 to about 3:1. In one embodiment, a molar ratio of about 4:1 is used. It is contemplated that such molar ratios may also be used in other suitable synthesis processes.
If desired, a coupling catalyst may be used to facilitate reaction of the epihalohydrin and diphenol. An example of a suitable such catalyst is an ammonium chloride salt such as, e.g., butyl trimethyl ammonium chloride. Such catalysts may be included at any suitable concentration level in the reaction mixture, including from about 2% to about 10% weight percent relative to the level of the diphenol reactant (e.g., TMBPF) in the reaction mixture.
Typically, the synthesis process will include one or more (or all) of the following steps after reaction of the epihalohydrin (typically epichlorohydrin) and diphenol has completed or is well underway: (i) removing excess epihalohydrin in one or more steps (e.g., via application of vacuum and/or heat), (ii) dehydrohalogenating the composition in one or more steps (before and/or after removing any excess epihalohydrin) to achieve a suitably low level of hydrolyzable chloride content, and (iii) washing out salts (e.g., NaCl via an aqueous work-up) that may have been generated in any dehydrohalogenating step(s). Suitable dehydrohalogenating agents that can be employed include alkali metal hydroxides such as, for example, sodium hydroxide, potassium hydroxide, lithium hydroxide, and mixtures thereof.
It is contemplated that the liquid epoxy resin composition may be used to make any type of polymer in which a diepoxide reactant is typically used, including, for example, polymers for use in the coatings or adhesives industries. The liquid diepoxide resin compositions disclosed herein are particularly useful for use in making polyether polymers for use in the coating industry, including the types of polyether binder polymers used to formulate coating compositions intended for use on the interior or exterior surfaces of food or beverage containers (e.g., metal food or beverage cans or portions thereof). Such polyether polymers, including suitable ingredients and processes for use in making such polymers, are described in U.S. Pub. Nos. 2013/0206756 and 2015/0021323.
In general, the molecular weight of the diepoxide resin composition is “upgraded” via reaction with one or more extender compounds to yield a polyether polymer having the desired molecular weight and balance of other desired characteristics. Examples of suitable such extenders may include polyols (with diols being preferred and diphenols being particularly preferred), polyacids (with diacids being preferred), or phenol compounds having both a phenol hydroxyl group and a carboxylic group (e.g., para hydroxyl benzoic acid and/or para hydroxy phenyl acetic acid). In some embodiments, catechol, hydroquinone, resorcinol, a substituted variant thereof, or mixtures thereof, are preferred extenders.
The polyether polymers may be made in a variety of molecular weights. Preferred polyether polymers have a number average molecular weight (Mn) of at least 2,000, more preferably at least 3,000, and even more preferably at least 4,000. The molecular weight of the polyether polymer may be as high as is needed for the desired application. Typically, however, the Mn of the polyether polymer, when adapted for use in a liquid coating composition, will not exceed about 11,000. In some embodiments, the polyether polymer has a Mn of about 5,000 to about 8,000. In embodiments where the polymer is a copolymer, such as for example a polyether-acrylic copolymer, the molecular weight of the overall polymer may be higher than that recited above, although the molecular weight of the polyether polymer portion will typically be as described above. Typically, however, such copolymers will have a Mn of less than about 20,000.
The polyether polymer may exhibit any suitable polydispersity index (PDI). In embodiments in which the polymer is a polyether polymer intended for use as a binder polymer of a liquid applied packaging coating (e.g., a food or beverage can coating), the polyether polymer will typically exhibit a PDI of from about 1.5 to 5, more typically from about 2 to 3.5, and in some instances from about 2.2 to 3 or about 2.4 to 2.8.
In certain preferred embodiments, the polyether polymer is suitable for use in formulating (e.g., as the primary binder polymer) a food-contact packaging coating. In order to facilitate a suitable balance of coating properties for use as a food-contact packaging coating, including suitable corrosion resistance when in prolonged contact with packaged food or beverage products which may be of a corrosive nature, the polymer preferably has a glass transition temperature (“Tg”) of at least 60° C., more preferably at least 70° C., and even more preferably at least 80° C. In preferred embodiments, the Tg is less than 150° C., more preferably less than 130° C., and even more preferably less than 110° C. Tg can be measured via differential scanning calorimetry (“DSC”) using the methodology disclosed in the Test Methods section. In preferred embodiments, the polymer is a polyether polymer exhibiting a Tg pursuant to the aforementioned Tg values. It is contemplated that, in some embodiments, such as, for example, where the coating composition is intended for use as an exterior varnish on a food or beverage container, the Tg of the polymer may be less than that described above (e.g., as low as about 30° C.).
While not intending to be bound by any theory, it is believed that the inclusion of a sufficient number of aryl and/or heteroaryl groups (typically phenylene groups) in the polyether polymer may be an important factor for achieving suitable coating performance for food-contact packaging coatings, especially when the product to be packaged is a so called “hard-to-hold” food or beverage product. Sauerkraut is an example of a hard-to-hold product. In preferred embodiments, aryl and/or heteroaryl groups constitute at least 25 wt-%, more preferably at least 30 wt-%, even more preferably at least 35 wt-%, and optimally at least 45 wt-% of the polyether polymer, based on the total weight of aryl and heteroaryl groups in the polymer relative to the weight of the polyether polymer. The upper concentration of aryl/heteroaryl groups is not particularly limited, but preferably the amount of such groups is configured such that the Tg of the polyether polymer is within the Tg ranges previously discussed. The total amount of aryl and/or heteroaryl groups in the polyether polymer will typically constitute less than about 80 wt-%, more preferably less than 75 wt-%, even more preferably less than about 70 wt-%, and optimally less than 60 wt-% of the polyether polymer. The total amount of aryl and/or heteroaryl groups in the polyether polymer can be determined based on the weight of aryl- or heteroaryl-containing monomer incorporated into the polyether polymer and the weight fraction of such monomer that constitutes aryl or heteroaryl groups. In embodiments where the polymer is a polyether copolymer (e.g., a polyether-acrylic copolymer), the weight fraction of aryl or heteroaryl groups in the polyether polymer portion(s) of the copolymer will generally be as described above, although the weight fraction relative to the total weight of the copolymer may be less.
Preferred aryl or heteroaryl groups include less than 20 carbon atoms, more preferably less than 11 carbon atoms, and even more preferably less than 8 carbon atoms. The aryl or heteroaryl groups preferably have at least 4 carbon atoms, more preferably at least 5 carbon atoms, and even more preferably at least 6 carbon atoms. Substituted or unsubstituted phenylene groups are preferred aryl or heteroaryl groups. Thus, in preferred embodiments, the polyether fraction of the polymer includes an amount of phenylene groups pursuant to the amounts recited above.
In some embodiments, at least 25%, at least 50%, or even at least 60% by weight of the polyether polymer constitutes structural units derived from the liquid epoxy resin composition.
Unless indicated otherwise, the following test methods were utilized in the Examples that follow.
The HCC was determined using Test Method A of ASTM D1726-11 entitled “Standard Test Methods for Hydrolyzable Chloride Content of Liquid Epoxy Resins.”
The liquid epoxy resin at a nominal concentration of 10,000 ppm (1%) was prepared in acetonitrile. This was diluted to 100 ppm with acetonitrile:water (50:50 v/v). The sample was analyzed by liquid chromatography with ultraviolet detection (LC/UV) using a Series 200 high performance liquid chromatograph (HPLC) (PerkinElmer, Waltham, Mass.) with the following conditions:
The structure of each peak is determined by Chemical ionization mass spectrometry. The weight percent of each peak is assumed to be proportional to the area under each peak.
Samples for differential scanning calorimetry (“DSC”) testing are prepared by first applying the liquid resin composition onto aluminum sheet panels. The panels are then baked in a Fisher Isotemp electric oven for 20 minutes at 300° F. (149° C.) to remove volatile materials. After cooling to room temperature, the samples are scraped from the panels, weighed into standard sample pans and analyzed using the standard DSC heat-cool-heat method. The samples are equilibrated at −60° C., then heated at 20° C. per minute to 200° C., cooled to −60° C., and then heated again at 20° C. per minute to 200° C. Glass transitions are calculated from the thermogram of the last heat cycle. The glass transition are measured at the inflection point of the transition.
The invention is illustrated by the following examples. It is to be understood that the particular examples, materials, amounts, and procedures are to be interpreted broadly in accordance with the scope and spirit of the inventions as set forth herein. Unless otherwise indicated, all parts and percentages are by weight and all molecular weights are weight average molecular weight. Unless otherwise specified, all chemicals used are commercially available from, for example, Sigma-Aldrich, St. Louis, Mo.
375.3 parts of epichlorohydrin were added to a 4-neck flask equipped with a mechanical stirrer, nitrogen inlet, reflux condenser, and a heating mantle equipped with a thermocouple and temperature controlling device. The setup was inerted with nitrogen, stirring was begun and 86.6 parts of TMBPF was added. Once the mixture was homogeneous, it was heated to 85° C., at which time 8.4 parts of a 60% solution of Butyl trimethyl ammonium chloride in water was added over approximately 1 hour to keep the temperature between 85-90° C. After the addition was complete, the mixture was held at 85-90° C. for 4 hours. At this point the mixture was tested by HPLC for residual TMBPF on the hour. When the residual TMBPF was less than 1% (which occurred after 8 hours), the reactor was cooled to 55° C., and 79 parts of 25% aqueous sodium hydroxide was added and held with agitation for 1 hour at 55° C. At this point agitation was stopped, and the layers were allowed to separate. When a relatively clean interface was observed, the salt water layer (bottom layer) was removed. Agitation was commenced and the organic layer was equilibrated at 55° C., and 30.4 parts of 25% aqueous sodium hydroxide was added. After agitation at 55° C. for 30 minutes, 36.5 parts of water was added, and held with agitation at 55° C. for 1 hour. Agitation was stopped, and the bottom layer was removed. The organic layer was tested for hydrolysable chloride content, which was determined to be less than 0.5% by weight. At this point, vacuum was applied slowly. When the vacuum reached greater than 25 inHg (inches of mercury), heat was slowly applied to reach 122° C. When epichlorohydrin stopped being collected, the material was tested for % epichlorohydrin. If the weight percent epichlorohydrin was less than 0.2% (if the value was greater than 0.2%, stripping was continued), vacuum was broken, the mixture was cooled to 55° C., and 250.3 parts of toluene and 30.9 parts isopropanol were added under agitation and heated to 55° C. 14.9 parts of 50% aqueous sodium hydroxide was added and mixed for 1 hour, then 17.9 parts water was added. The top layer was tested for % hydrolyzable chloride content (HCC). If the % HCC was less than 0.01%, the bottom layer was removed (if % HCC was 0.01%, additional caustic treatments were performed), and an equal volume of water was added. The two layers were heated to 50° C. with agitation for 30 minutes, at which time, agitation was stopped and the layers were allowed to separate. The bottom layer was removed and 124.3 parts of a 0.4% aqueous solution of monosodium phosphate was added. The layers were heated to 50° C. with agitation for 30 minutes. The bottom layer was removed and an equal volume of water was added and heated to 50° C. with agitation for 30 minutes. Agitation was stopped, the layers were allowed to separate, and the aqueous layer was removed. This was repeated until the organic layer was completely clear, indicating all the salt was washed out. At this point, the toluene was stripped out at 122° C. under vacuum, leaving a TMBPF diglycidyl ether resin composition with the properties indicated in Table 1.
168.22 parts of epichlorohydrin were added to a 4-neck flask equipped with a mechanical stirrer, nitrogen inlet, reflux condenser, and a heating mantle equipped with a thermocouple and temperature controlling device. The setup was inerted with nitrogen, stirring was begun and 116.53 parts of TMBPF was added. Once the mixture was homogeneous, it was heated to 85° C., at which time 2.81 parts of a 60% solution of Butyl trimethyl ammonium chloride in water was added over approximately 1 hour to keep the temperature between 85-90° C. After the addition was complete, the mixture was held at 85-90° C. for 40 hours. At this point the mixture is tested by HPLC for residual TMBPF on the hour. When the residual TMBPF is <1% (40 hours), the reactor is cooled to 55° C., and 106.2 parts of 25% aqueous sodium hydroxide was added and held with agitation for 1 hour at 55° C. At this point agitation was stopped, and the layers were allowed to separate. When a relatively clean interface was observed, the salt-water layer (bottom layer) was removed. Agitation was commenced and the organic layer was equilibrated at 55° C., and 40.95 parts of 25% aqueous sodium hydroxide was added. After agitation at 55° C. for 30 minutes, 49.14 parts of water was added, and held with agitation at 55° C. for 1 hour. Agitation was stopped, and the bottom layer was removed. The organic layer was tested for hydrolyzable chloride content. It was less than 0.5% by weight. At this point vacuum was applied slowly. When the vacuum reached less than 25 inHg, heat was slowly applied to reach 122° C. When epichlorohydrin stopped being collected, the material was tested for % epichlorohydrin. If weight percent of epichlorohydrin was less than 0.2% (if the value was greater than 0.2%, stripping was continued), vacuum was broken, the mixture was cooled to 55° C. and 336.6 parts of toluene and 41.6 parts isopropanol were added under agitation and heated to 55° C. 20.0 parts of 50% aqueous sodium hydroxide was added and mixed for 1 hour, then 24 parts water was added. The top layer was tested for % hydrolyzable chloride content (HCC). If the weight percent HCC was less than 0.01%, the bottom layer was removed (if wt-% HCC was greater than 0.01%, additional caustic treatments were performed), and an equal volume of water was added. The two layers were heated to 50° C. with agitation for 30 minutes, at which time, agitation was stopped and the layers were allowed to separate. The bottom layer was removed and 167.14 parts of a 0.4% aqueous solution of monosodium phosphate was added. The layers were heated to 50° C. with agitation for 30 minutes. The bottom layer was removed and an equal volume of water was added and heated to 50° C. with agitation for 30 minutes. Agitation was stopped, the layers were allowed to separate, and the aqueous layer was removed. This was repeated until the organic layer was completely clear, indicating all the salt was washed out. At this point, the toluene was stripped out at 122° C. under vacuum, leaving a TMBPF digylcidylether resin composition with the properties indicated below in Table 2. The liquid epoxy resin composition was storage stable under ambient conditions for more than 3 months and was viable for up to about 6 months of storage under ambient conditions.
405.3 parts of the liquid epoxy resin from Example 1, 94.5 parts hydroquinone, 0.5 parts ethyl triphenyl phosphonium iodide, and 15.5 parts ethyl carbitol were added to a 4-neck flask equipped with a mechanical stirrer, nitrogen inlet, reflux condenser, and a heating mantle equipped with a thermocouple and temperature controlling device. The setup was inerted with nitrogen, stirring was begun and the batch was heated to 130° C. Heat was then turned off and the batch was allowed to exotherm to 180° C. The batch was stabilized at 160 C until the weight per epoxide was 2083. At this point the temperature was turned off and the following solvents were added sequentially: 106.5 parts cyclohexanone, 232.4 parts aromatic 100, and 145.3 parts PM acetate. The polyether polymer had a solids of 50% and a weight per epoxide of 2128, and a viscosity of 11,000 cps. When this polymer was formulated with resole phenolic resin, it had flexibility and corrosion resistance similar to food-contact can coating industry standards.
A liquid epoxy resin synthesized using epichlorohydrin and TMBPF produced using a different method than that of Example 1 was provided. The properties of the liquid diepoxide resin composition of Example 3 are provided below in Table 3. The liquid epoxy resin composition was storage stable for an extended period of time (e.g., months) under ambient conditions. When tested using the Pour Test described herein, the liquid epoxy resin composition began pouring out of the beaker within approximately 5 to 10 minutes (after the beaker was turned upside-down) in a continuous “string” that broke at 126 minutes.
The liquid epoxy resin composition of Example 3 was used to successfully generate a polyether polymer (using the methods of Example 2 and other materials of Example 2) that was suitable for use in formulating an interior food or beverage can coating composition
The complete disclosure of all patents, patent applications, and publications, and electronically available material cited herein are incorporated by reference. The foregoing detailed description and examples have been given for clarity of understanding only. No unnecessary limitations are to be understood therefrom. The invention is not limited to the exact details shown and described, for variations obvious to one skilled in the art will be included within the invention defined by the claims. The invention illustratively disclosed herein suitably may be practiced, in some embodiments, in the absence of any element which is not specifically disclosed herein.
This application claims the benefit of U.S. Provisional Application No. 62/250,217 filed on Nov. 3, 2015 and entitled “Liquid Epoxy Resin Composition Useful For Making Polymers,” which is incorporated herein by reference in its entirety.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2016/060332 | 11/3/2016 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/079437 | 5/11/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
2500449 | Bradley | Mar 1950 | A |
2528933 | Wiles | Nov 1950 | A |
2633458 | Shokal | Mar 1953 | A |
2681901 | Wiles et al. | Jun 1954 | A |
2694694 | Owen et al. | Nov 1954 | A |
2767157 | Masters et al. | Oct 1956 | A |
2824855 | Freeman et al. | Feb 1958 | A |
2951778 | Haberlin | Sep 1960 | A |
3006891 | Leroy et al. | Oct 1961 | A |
3041300 | Morrison | Jun 1962 | A |
3085992 | Lee et al. | Apr 1963 | A |
3102043 | Arthur et al. | Aug 1963 | A |
3121727 | Baliker, Jr. et al. | Feb 1964 | A |
3153008 | Fox | Oct 1964 | A |
3220974 | Fox | Nov 1965 | A |
3275601 | Schnell et al. | Sep 1966 | A |
3288884 | Sonnabend et al. | Nov 1966 | A |
3297724 | McConnell et al. | Jan 1967 | A |
3313775 | Frankel | Apr 1967 | A |
3321424 | Imes et al. | May 1967 | A |
3366600 | Haberlin et al. | Jan 1968 | A |
3379684 | Wiesner et al. | Apr 1968 | A |
3404102 | Starcher et al. | Oct 1968 | A |
3475266 | Albert | Oct 1969 | A |
3477990 | Mark et al. | Nov 1969 | A |
3480695 | Warren | Nov 1969 | A |
3491111 | Lin | Jan 1970 | A |
3491112 | Lin | Jan 1970 | A |
3491116 | Lin | Jan 1970 | A |
3509174 | Lin | Apr 1970 | A |
3553119 | Wright et al. | Jan 1971 | A |
3578615 | Moore et al. | May 1971 | A |
3624107 | Lin | Nov 1971 | A |
3627787 | Lin | Dec 1971 | A |
3641011 | Lin et al. | Feb 1972 | A |
3642828 | Farber et al. | Feb 1972 | A |
3681390 | Lin | Aug 1972 | A |
3775424 | Farber | Nov 1973 | A |
3853869 | Farber | Dec 1974 | A |
3876606 | Kehr | Apr 1975 | A |
3879348 | Serini et al. | Apr 1975 | A |
3888812 | Plettner | Jun 1975 | A |
3905926 | D'Alelio | Sep 1975 | A |
3920510 | Hatano et al. | Nov 1975 | A |
3943187 | Wu et al. | Mar 1976 | A |
3950451 | Hirosi et al. | Apr 1976 | A |
3959571 | Yahagi et al. | May 1976 | A |
RE28862 | Siemonsen et al. | Jun 1976 | E |
3971808 | Baumann et al. | Jul 1976 | A |
3984363 | D'Alelio | Oct 1976 | A |
4009224 | Warnken | Feb 1977 | A |
4011184 | Van et al. | Mar 1977 | A |
4051195 | McWhorter | Sep 1977 | A |
4076676 | Sommerfeld et al. | Feb 1978 | A |
4076764 | Bauer | Feb 1978 | A |
4111910 | Baggett | Sep 1978 | A |
4122060 | Yallourakis | Oct 1978 | A |
4172103 | Cohen et al. | Oct 1979 | A |
4173594 | Dyszlewski | Nov 1979 | A |
4212781 | Evans et al. | Jul 1980 | A |
4247439 | Matthews et al. | Jan 1981 | A |
4283428 | Birkmeyer | Aug 1981 | A |
4285847 | Ting et al. | Aug 1981 | A |
4333809 | Schreckenberg et al. | Jun 1982 | A |
4340716 | Hata et al. | Jul 1982 | A |
4368315 | Sikdar | Jan 1983 | A |
4374233 | Loucks et al. | Feb 1983 | A |
4399241 | Ting et al. | Aug 1983 | A |
4413015 | Anderson et al. | Nov 1983 | A |
4446258 | Chu et al. | May 1984 | A |
4468483 | Yeakey et al. | Aug 1984 | A |
4476262 | Chu et al. | Oct 1984 | A |
4487861 | Winner | Dec 1984 | A |
4510513 | Yamaguchi et al. | Apr 1985 | A |
4517322 | Birkmeyer et al. | May 1985 | A |
4522984 | Watanabe et al. | Jun 1985 | A |
4552814 | Cavitt et al. | Nov 1985 | A |
4564655 | Liu | Jan 1986 | A |
4600737 | Georgalas et al. | Jul 1986 | A |
4622368 | Verbicky, Jr. et al. | Nov 1986 | A |
4647612 | Ranka et al. | Mar 1987 | A |
4665149 | Bertram et al. | May 1987 | A |
4707534 | Schultz | Nov 1987 | A |
4729983 | Satake et al. | Mar 1988 | A |
4757132 | Brunelle et al. | Jul 1988 | A |
4794102 | Petersen et al. | Dec 1988 | A |
4794156 | Ho et al. | Dec 1988 | A |
4806597 | Gallucci et al. | Feb 1989 | A |
4849502 | Evans et al. | Jul 1989 | A |
4880892 | Urano et al. | Nov 1989 | A |
4963602 | Patel | Oct 1990 | A |
4994217 | Banevicius et al. | Feb 1991 | A |
5010147 | Westeppe et al. | Apr 1991 | A |
5068284 | Ullman et al. | Nov 1991 | A |
5080961 | Macy et al. | Jan 1992 | A |
5102608 | Frencken et al. | Apr 1992 | A |
5115082 | Mercer et al. | May 1992 | A |
5162406 | Meyer et al. | Nov 1992 | A |
5201436 | Owens et al. | Apr 1993 | A |
5212241 | Woo et al. | May 1993 | A |
5264503 | Marx et al. | Nov 1993 | A |
5288839 | Greco | Feb 1994 | A |
5296525 | Spencer et al. | Mar 1994 | A |
5446009 | Minami et al. | Aug 1995 | A |
5494950 | Asakage et al. | Feb 1996 | A |
5496921 | Sakashita et al. | Mar 1996 | A |
5527840 | Chutko et al. | Jun 1996 | A |
5567781 | Martino et al. | Oct 1996 | A |
5571907 | Sachinala et al. | Nov 1996 | A |
5576413 | Bussink et al. | Nov 1996 | A |
5591788 | Anderson et al. | Jan 1997 | A |
5623031 | Imura et al. | Apr 1997 | A |
5677398 | Motoshima et al. | Oct 1997 | A |
5686185 | Correll et al. | Nov 1997 | A |
5718352 | Diekhoff et al. | Feb 1998 | A |
5718353 | Kanfer et al. | Feb 1998 | A |
5803301 | Sato et al. | Sep 1998 | A |
5807912 | Wu et al. | Sep 1998 | A |
5811498 | Perumal et al. | Sep 1998 | A |
5830952 | Pedersen et al. | Nov 1998 | A |
5859172 | Sakashita et al. | Jan 1999 | A |
5872196 | Murata et al. | Feb 1999 | A |
5880248 | Sakashita et al. | Mar 1999 | A |
5916933 | Johnson et al. | Jun 1999 | A |
5922817 | Pedersen et al. | Jul 1999 | A |
5925694 | Stengel-Rutkowski et al. | Jul 1999 | A |
5994462 | Srinivasan et al. | Nov 1999 | A |
6008273 | Leibelt et al. | Dec 1999 | A |
6034157 | Craun et al. | Mar 2000 | A |
6043333 | Kuboki et al. | Mar 2000 | A |
6048931 | Fujita et al. | Apr 2000 | A |
6060577 | Davis | May 2000 | A |
6133402 | Coates et al. | Oct 2000 | A |
6201070 | Kumabe et al. | Mar 2001 | B1 |
6225436 | Eiffler et al. | May 2001 | B1 |
6242533 | Kurimoto et al. | Jun 2001 | B1 |
6306934 | Bode et al. | Oct 2001 | B1 |
6376021 | Spellane | Apr 2002 | B1 |
6382454 | Buffard et al. | May 2002 | B1 |
6399738 | Ito | Jun 2002 | B1 |
6469127 | Furunaga et al. | Oct 2002 | B1 |
6472472 | Jung et al. | Oct 2002 | B2 |
6566426 | Kanaida et al. | May 2003 | B1 |
6576718 | Yeager et al. | Jun 2003 | B1 |
6579829 | Nishimura et al. | Jun 2003 | B2 |
6608163 | Bailly et al. | Aug 2003 | B2 |
6660688 | Yamada et al. | Dec 2003 | B2 |
6706350 | Sato et al. | Mar 2004 | B2 |
6777464 | Watanabe et al. | Aug 2004 | B1 |
6784228 | Ogura et al. | Aug 2004 | B2 |
6794445 | Reusmann et al. | Sep 2004 | B2 |
6808752 | Mallen | Oct 2004 | B2 |
6833398 | Agarwal et al. | Dec 2004 | B2 |
6844071 | Wang et al. | Jan 2005 | B1 |
6894093 | Bittner | May 2005 | B2 |
6916874 | Mazza et al. | Jul 2005 | B2 |
6924328 | Legleiter et al. | Aug 2005 | B2 |
6984262 | King et al. | Jan 2006 | B2 |
6984608 | Makitalo et al. | Jan 2006 | B2 |
7022765 | Adedeji et al. | Apr 2006 | B2 |
7037584 | Wind et al. | May 2006 | B2 |
7063914 | Kawano et al. | Jun 2006 | B2 |
7078077 | Lynch et al. | Jul 2006 | B2 |
7150902 | Farha | Dec 2006 | B2 |
7157119 | Tang et al. | Jan 2007 | B2 |
7189787 | O'Brien et al. | Mar 2007 | B2 |
7198849 | Stapperfenne et al. | Apr 2007 | B2 |
7208538 | Taylor et al. | Apr 2007 | B2 |
7256228 | Agarwal et al. | Aug 2007 | B2 |
7262261 | Brindopke et al. | Aug 2007 | B2 |
7332557 | Shinohara et al. | Feb 2008 | B2 |
7332560 | Heuer et al. | Feb 2008 | B2 |
7397139 | Ikezawa et al. | Jul 2008 | B2 |
7446234 | More et al. | Nov 2008 | B2 |
7544727 | Ikezawa et al. | Jun 2009 | B2 |
7585904 | Nakamura | Sep 2009 | B2 |
7592047 | O'Brien et al. | Sep 2009 | B2 |
7619056 | East et al. | Nov 2009 | B2 |
7635662 | Kabashima et al. | Dec 2009 | B2 |
7666953 | Nakamura et al. | Feb 2010 | B2 |
7675185 | Tendou et al. | Mar 2010 | B2 |
7682674 | Vogt et al. | Mar 2010 | B2 |
7709582 | Kouchi et al. | May 2010 | B2 |
7803439 | Crawford et al. | Sep 2010 | B2 |
7803440 | Crawford et al. | Sep 2010 | B2 |
7820772 | Usui et al. | Oct 2010 | B2 |
7838577 | Hayakawa et al. | Nov 2010 | B2 |
7846998 | Akagi et al. | Dec 2010 | B2 |
7910170 | Evans et al. | Mar 2011 | B2 |
7915743 | Ishizawa et al. | Mar 2011 | B2 |
7981511 | Maenaka et al. | Jul 2011 | B2 |
7981515 | Ambrose et al. | Jul 2011 | B2 |
7985522 | Tajima et al. | Jul 2011 | B2 |
8013052 | Nakamura et al. | Sep 2011 | B2 |
8110614 | Ito et al. | Feb 2012 | B2 |
8129495 | Evans et al. | Mar 2012 | B2 |
8142858 | Mayr et al. | Mar 2012 | B2 |
8168276 | Cleaver et al. | May 2012 | B2 |
8168721 | Marsh et al. | May 2012 | B2 |
8178598 | Hakuya | May 2012 | B2 |
8449960 | Skillman et al. | May 2013 | B2 |
8465846 | O'Brien et al. | Jun 2013 | B2 |
8492467 | Yamaguchi | Jul 2013 | B2 |
8519085 | Evans et al. | Aug 2013 | B2 |
8927075 | Gibanel et al. | Jan 2015 | B2 |
9409219 | Niederst et al. | Aug 2016 | B2 |
9475328 | Niederst et al. | Oct 2016 | B2 |
9540484 | Craun et al. | Jan 2017 | B2 |
9605177 | Tang et al. | Mar 2017 | B2 |
9724276 | Niederst et al. | Aug 2017 | B2 |
9944749 | Niederst et al. | Apr 2018 | B2 |
1011302 | Niederst et al. | Oct 2018 | A1 |
20030170396 | Yokoi et al. | Sep 2003 | A1 |
20030171527 | Burgoyne et al. | Sep 2003 | A1 |
20030181628 | Horn et al. | Sep 2003 | A1 |
20030203991 | Schottman et al. | Oct 2003 | A1 |
20030209553 | Horn et al. | Nov 2003 | A1 |
20030232145 | Inomata et al. | Dec 2003 | A1 |
20040044101 | Hirose et al. | Mar 2004 | A1 |
20040092674 | Brindopke et al. | May 2004 | A1 |
20040110908 | Idemura et al. | Jun 2004 | A1 |
20040171746 | Parekh et al. | Sep 2004 | A1 |
20040176563 | Shinohara et al. | Sep 2004 | A1 |
20040214916 | Patel et al. | Oct 2004 | A1 |
20040214926 | Bittner | Oct 2004 | A1 |
20040220372 | Qi et al. | Nov 2004 | A1 |
20050014004 | King et al. | Jan 2005 | A1 |
20050075465 | Bolle et al. | Apr 2005 | A1 |
20050090044 | Kayaba et al. | Apr 2005 | A1 |
20050090593 | Heuer et al. | Apr 2005 | A1 |
20050131195 | Asakage | Jun 2005 | A1 |
20050196629 | Bariatinsky et al. | Sep 2005 | A1 |
20050215670 | Shimasaki et al. | Sep 2005 | A1 |
20060025559 | Wehrmann et al. | Feb 2006 | A1 |
20060052523 | Bushendorf et al. | Mar 2006 | A1 |
20060134541 | Fujii et al. | Jun 2006 | A1 |
20060142442 | Scherzer et al. | Jun 2006 | A1 |
20070036903 | Mayr et al. | Feb 2007 | A1 |
20070065589 | Florian | Mar 2007 | A1 |
20070065608 | Niederst | Mar 2007 | A1 |
20070087146 | Evans et al. | Apr 2007 | A1 |
20070099130 | Takahashi et al. | May 2007 | A1 |
20070154643 | Schmid et al. | Jul 2007 | A1 |
20070281179 | Ambrose et al. | Dec 2007 | A1 |
20080009599 | East et al. | Jan 2008 | A1 |
20080033080 | Mader et al. | Feb 2008 | A1 |
20080171195 | Gothlich et al. | Jul 2008 | A1 |
20080193689 | Masselin et al. | Aug 2008 | A1 |
20080246173 | Braidwood et al. | Oct 2008 | A1 |
20080251757 | Yamamoto et al. | Oct 2008 | A1 |
20080319102 | Eckert et al. | Dec 2008 | A1 |
20080319156 | Fischer et al. | Dec 2008 | A1 |
20090036631 | Kaji | Feb 2009 | A1 |
20090068473 | Van Wessel et al. | Mar 2009 | A1 |
20090088535 | Arita et al. | Apr 2009 | A1 |
20090092827 | Robinson | Apr 2009 | A1 |
20090158963 | O'Dell et al. | Jun 2009 | A1 |
20090247032 | Mori et al. | Oct 2009 | A1 |
20090280423 | Yahiro et al. | Nov 2009 | A1 |
20090281224 | Koh et al. | Nov 2009 | A1 |
20090326107 | Bittner | Dec 2009 | A1 |
20100056663 | Ito et al. | Mar 2010 | A1 |
20100056721 | Wright et al. | Mar 2010 | A1 |
20100056726 | Payot et al. | Mar 2010 | A1 |
20100068433 | Gibanel et al. | Mar 2010 | A1 |
20100086716 | Ruediger et al. | Apr 2010 | A1 |
20100143681 | Yano et al. | Jun 2010 | A1 |
20100285309 | Barriau et al. | Nov 2010 | A1 |
20110042338 | Pecorini et al. | Feb 2011 | A1 |
20110160408 | De Brouwer et al. | Jun 2011 | A1 |
20110294921 | Smith | Dec 2011 | A1 |
20110315591 | Lespinasse et al. | Dec 2011 | A1 |
20120125800 | Doreau et al. | May 2012 | A1 |
20120149340 | Selph et al. | Jun 2012 | A1 |
20120165429 | Boutevin et al. | Jun 2012 | A1 |
20120172568 | Ueda | Jul 2012 | A1 |
20120282475 | Fuhry et al. | Nov 2012 | A1 |
20120301645 | Moussa et al. | Nov 2012 | A1 |
20120301646 | List et al. | Nov 2012 | A1 |
20120301647 | Moussa et al. | Nov 2012 | A1 |
20120302690 | Cunningham et al. | Nov 2012 | A1 |
20130052381 | Gallucci et al. | Feb 2013 | A1 |
20130196037 | O'Brien et al. | Aug 2013 | A1 |
20130206756 | Niederst et al. | Aug 2013 | A1 |
20130280455 | Evans et al. | Oct 2013 | A1 |
20130316109 | Niederst et al. | Nov 2013 | A1 |
20130324652 | Pompignano et al. | Dec 2013 | A1 |
20140113093 | Corbin et al. | Apr 2014 | A1 |
20140322465 | Kaleem et al. | Oct 2014 | A1 |
20140378565 | Gelmont | Dec 2014 | A1 |
20150021323 | Niederst et al. | Jan 2015 | A1 |
20150151878 | Niederst et al. | Jun 2015 | A1 |
20150197657 | Niederst et al. | Jul 2015 | A1 |
20150203713 | Niederst et al. | Jul 2015 | A1 |
20160107818 | Kaleem et al. | Apr 2016 | A1 |
20160122581 | You et al. | May 2016 | A1 |
20160272576 | Gibanel et al. | Sep 2016 | A1 |
20170029657 | Niederst et al. | Feb 2017 | A1 |
20170051177 | Prouvost et al. | Feb 2017 | A1 |
20170088745 | Matthieu et al. | Mar 2017 | A1 |
20170096521 | Niederst et al. | Apr 2017 | A1 |
20180112101 | Evans et al. | Apr 2018 | A1 |
20180112102 | Evans et al. | Apr 2018 | A1 |
Number | Date | Country |
---|---|---|
2280409 | Feb 2001 | CA |
2570312 | Jan 2006 | CA |
2280409 | May 2008 | CA |
101096411 | Jan 2008 | CN |
101244290 | Aug 2008 | CN |
101484548 | Jul 2009 | CN |
104479105 | Apr 2015 | CN |
0265791 | May 1988 | EP |
0475359 | Mar 1992 | EP |
0620238 | Oct 1994 | EP |
0185118 | Sep 1995 | EP |
1333075 | Aug 2003 | EP |
1818350 | Aug 2007 | EP |
S63304068 | Dec 1988 | JP |
H0255727 | Feb 1990 | JP |
H07126574 | May 1995 | JP |
H07138502 | May 1995 | JP |
H07196770 | Aug 1995 | JP |
H08151428 | Jun 1996 | JP |
H08230328 | Sep 1996 | JP |
2000005019 | Jan 2000 | JP |
2000-007757 | Jul 2001 | JP |
2000-007891 | Jul 2001 | JP |
2002097250 | Apr 2002 | JP |
2002097409 | Apr 2002 | JP |
2002138245 | May 2002 | JP |
2002155727 | May 2002 | JP |
2002220563 | Aug 2002 | JP |
2003012763 | Jan 2003 | JP |
2003176348 | Jun 2003 | JP |
2003178348 | Jun 2003 | JP |
2003183352 | Jul 2003 | JP |
3484546 | Jan 2004 | JP |
2004010874 | Jan 2004 | JP |
2004053016 | Feb 2004 | JP |
2005320446 | Nov 2005 | JP |
2006176658 | Jul 2006 | JP |
2011-207932 | Apr 2013 | JP |
100804293 | Feb 2008 | KR |
WO-9526997 | Oct 1995 | WO |
WO-9728905 | Aug 1997 | WO |
WO-0071337 | Nov 2000 | WO |
WO-2004050740 | Jun 2004 | WO |
WO-2007048094 | Apr 2007 | WO |
WO-2007054304 | May 2007 | WO |
WO-2008137562 | Nov 2008 | WO |
WO-2009015493 | Feb 2009 | WO |
WO-2009036790 | Mar 2009 | WO |
WO-2009089145 | Jul 2009 | WO |
WO-2010118349 | Oct 2010 | WO |
WO-2010118356 | Oct 2010 | WO |
WO-2010134608 | Nov 2010 | WO |
WO-2011130671 | Oct 2011 | WO |
WO-2012091701 | Jul 2012 | WO |
WO-2012109278 | Aug 2012 | WO |
WO-2012149340 | Nov 2012 | WO |
WO-2012151184 | Nov 2012 | WO |
WO-2012161758 | Nov 2012 | WO |
WO-2012162298 | Nov 2012 | WO |
WO-2012162299 | Nov 2012 | WO |
WO 2013028607 | Feb 2013 | WO |
WO-2013119686 | Aug 2013 | WO |
WO-2013149234 | Oct 2013 | WO |
WO-2013169459 | Nov 2013 | WO |
WO-2014025997 | Feb 2014 | WO |
WO-2014140233 | Sep 2014 | WO |
WO-2014140234 | Sep 2014 | WO |
WO-2016201407 | Dec 2016 | WO |
Entry |
---|
CertiChem Inc., “Test Method Nomination: MCF-7 Cell Proliferation Assay of Estrogenic Activity,” National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM), Jan. 2006, 102 pages, Retrieved from the Internet [URL: https://ntp.niehs.nih.gov/iccvam/methods/endocrine/endodocs/submdoc.pdf]. |
Declaration of Dr. Larry B. Brandenburger under 37 C.P.R. §1.132 for Control No. 95/001,950 Concerning Inter Partes Reexamination of U.S. Pat. No. 8,092,876, 12 pages. |
Dow Chemical Company., “D.E.R.™ 661, Solid Epoxy Resin,” Product Information Form No. 296-01462-1007X-TD, 3 pages. |
DYTEK® A-Amine, Downloaded from the Oct. 16, 2014, Internet Archives capture at [https://web.archive.org/web/20141016043145/http://dytek.invista.com/Products/Amines/dytek-a-amine]. |
Eastman, “Eastman TritanTM Copolyester—Lack of Estrogen and Testosterone Activity,” TRS-270, Apr. 2010, 3 pages. |
European Search Report for Application No. 12744671.4, dated Dec. 17, 2015, 5 pages. |
European Search Report for Application No. 12790169.2, dated Nov. 26, 2015, 5 pages. |
European Search Report for Application No. 17182623.3, dated Oct. 11, 2017, 8 pages. |
Extended European Search Report for Application No. 15779232.6, dated Feb. 23, 2018, 13 pages. |
Extended European Search Report for Application No. EP13827304, dated Mar. 21, 2016, 11 pages. |
Fang H., et al., “Quantitative Comparisons of in Vitro Assays for Estrogenic Activities,” Environmental Health Perspectives, Aug. 2000, vol. 108 (8), pp. 723-729. |
Fang H., et al., “Structure-Activity Relationships for a Large Diverse Set of Natural, Synthetic, and Environmental Estrogens,” Chemical Research in Toxicology, Mar. 2001, vol. 14 (3), pp. 280-294. |
First Office Action dated Oct. 31, 2018 for Chinese Application No. 201610835512.9, 7 pages. |
“Flame Retardant Bisphenol F”, Product Information Sheets, Nippon Kasei Chemical, 2013, 2 pages. |
Flick E.W., “Epoxy Resins, Curing Agents, Compounds, and Modifiers—An Industrial Guide,” Second Edition, 1993, 10 pages. available at http://www.daryatamin.com/uploads/Books%20File/Epoxy%20Resins,%20Curing%20Agents,%20Compounds,%20and%20Modifiers%20An%20Industrial%20Guide.pdf. |
Grace Darex® Packaging Technologies, A Global Partner for Your Global Business, Product Book, 2006, 4 pages. |
Guilin, et al., “Environmentally friendly paint formulation design,” Chemical Industry Press, ISBN: 978-7-5025-9943-0, 2007, pp. 207-209 (6 pages). |
Hashimoto Y., et al., “Measurement of Estrogenic Activity of Chemicals for the Development of New Dental Polymers,” Toxicology in Vitro, 2001, vol. 15 (4-5), pp. 421-425. |
International Preliminary Report on Patentability for Application No. PCT/US2011/032738, dated Oct. 26, 2012, 5 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2012/024191, dated Aug. 22, 2013, 7 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2012/024193, dated Aug. 22, 2013, 7 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2013/024960, dated Aug. 21, 2014, 9 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2016/060332, dated May 17, 2018, 8 pages. |
International Search Report and Written Opinion for Application No. PCT/US2011/032738 dated Jan. 18, 2012, 13 pages. |
International Search Report and Written Opinion for Application No. PCT/US2012/024191, dated Dec. 28, 2012, 13 pages. |
International Search Report and Written Opinion for Application No. PCT/US2012/024193 dated Oct. 31, 2012, 9 pages. |
International Search Report and Written Opinion for Application No. PCT/US2013/024960, dated May 31, 2013, 11 pages. |
International Search Report and Written Opinion for Application No. PCT/US2013/054132, dated Oct. 23, 2013, 10 pages. |
International Search Report and Written Opinion for Application No. PCT/US2015/025723, dated Jun. 29, 2015, 16 pages. |
International Search Report and Written Opinion for Application No. PCT/US2016/060332, dated Feb. 12, 2017, 10 pages. |
Jungang G., “Kinetics of Epoxy Resins Formation from Bisphenol-A,Bisphenol-S, and Epichlorohydrin,” Journal of Applied Polymer Science, vol. 48, 1993, pp. 237-241. |
Kitamura S., et al., “Comparative Study of the Endocrine-Disrupting Activity of Bisphenol A and 19 Related Compounds,” Toxicological Sciences, Jan. 5, 2005, vol. 84 (2), pp. 249-259. |
Kobayashi S., et al., “Stereo Structure-Controlled and Electronic Structure-Controlled Estrogen-Like Chemicals to Design and Develop Non-estrogenic Bisphenol A Analogs Based on Chemical Hardness Concept,” Chemical & Pharmaceutical Bulletin,Dec. 2006, vol. 54 (12), pp. 1633-1638. |
Liu Z., et al., “Preparation, Characterization and Thermal Properties of Tetramethylbisphenol F Exposy Resin and Mixed Systems,” Polymer International, Apr. 2012, vol. 61 (4), pp. 565-570. |
Matasa C.G., et al., “A Wish List for Orthodontic Materials, 2005,” The Orthodontic Materials Insider, Dec. 2004, vol. 16 (4), 8 pages. |
Matsumoto S., et al., “The Crystal Structure of Two New Developers for High-Performance Thermo-Sensitive Paper: H-Bonded Network in Urea-Urethane Derivatives,” Dyes and Pigments, May 2010, vol. 85 (3), pp. 139-142. |
Mendum T., et al., “Concentration of Bisphenol A in Thermal Paper,” Green Chemistry Letters and Reviews, Research Letter, Mar. 2011, vol. 4 (1), pp. 81-86. |
Mesnage, et al., “Transcriptome Profiling Reveals Bisphenol A Alternatives Activate Estrogen Receptor Alpha in Human Breast Cancer Cells,” Toxicological Sciences, 2017, vol. 158 (2), pp. 431-443. |
Meti, “Current Status of Testing Methods Development for Endocrine Disrupters,” 6th Meeting of the Task Force on Endocrine Disrupters Testing and Assessment (EDTA), Tokyo, Ministry of Economy, Trade and Industry, Japan, Jun. 24-25, 2002, 70 pages. |
Momentive Specialty Chemicals Inc.., “EPON™ and EPI-REZ™ Epoxy Resins,” Product Aug. 2013, 16 pages. |
Moss G.P., “Extension and Revision of the Von Baeyer System for Naming Polycyclic Compounds (Including Bicyclic Compounds),” Pure and Applied Chemistry, 1999, vol. 71 (3), pp. 513-529. |
Olsen C.M., et al., “Effects of the Environmental Oestrogens Bisphenol A, Tetrachlorobisphenol A, Tetrabromobisphenol A, 4-Hydroxybiphenyl and 4,4′-Dihydroxpiphenyl on Oestrogen Receptor Binding, Cell Proliferation and Regulation of Oestrogen Sensitive Proteins in the Human Breast Cancer Cell Line MCF-7,” Pharmacology and Toxicology, Apr. 2003, vol. 92 (4), pp. 180-188. |
Parent Application, U.S. Appl. No. 13/651,796, Evans et al., filed Oct. 15, 2012. |
Polycarbonates, 4th-5th Edition, Kirk-Othmer Encyclopedia of Chemical Technology, 2000, pp. 1-30. |
Poly(p-phenylene oxide), Wikipedia: The Free Encyclopedia, accessed Apr. 6, 2015, http://en.wikipedia.org/wiki/Poly(p-phenylene_oxide, 3 pages. |
Porter D.S., et al., “Hot-Fill Containers,” New Tech for OPP & PET, Plastics Technology, Eastman Chemical Co., Dec. 2007, 6 pages. |
Ravdin, et al., “Estrogenic Effects of Phenolphthalein on Human Breast Cancer Cells In Vitro,” Breast Cancer Research and Treatment, Jun. 1987, vol. 9 (2), pp. 151-154. |
Rosenmai, et al., “Are Structural Analogues to Bisphenol a Safe Alternatives?,” Toxicological Sciences, vol. 139 (1), 2014, pp. 35-47. |
Song K.H., et al., “Endocrine Disrupter Bisphenol a Induces Orphan Nuclear Receptor Nur77 Gene Expression and Steroidogenesis in Mouse Testicular Leydig Cells,” Endocrinology, Jun. 2002, vol. 143 (6), pp. 2208-2215. |
Soto A.M., “Evidence of Absence: Estrogenicity Assessment of a New Food-Contact Coating and the Bisphenol Used in Its Synthesis,” Environmental Science and Technology, 2017, vol. 51 (3), pp. 1718-1726. |
Extended European Search Report for Application No. 18166398.0, dated Oct. 26, 2018, 6 pages. |
Olin North America Epoxy Resins (2016) brochure available at: https://www.brenntag.com/media/documents/bsi/product_data_sheets/material_science/olin_epoxy_resins/olin_epoxy_resins_brochure.pdf, 12 pages. |
Extended European Search Report for Application No. 18150643.7, dated Oct. 26, 2018, 6 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2013/054132, dated Feb. 19, 2015, 8 pages. |
International Preliminary Report on Patentability for Application No. PCT/US2015/025723, dated Oct. 27, 2016, 11 pages. |
Supplementary European Search Report for Application No. 11769696.3, dated Jun. 27, 2014, 7 pages. |
Supplementary European Search Report for Application No. 13746877.3, dated Nov. 30, 2015, 8 pages. |
Supplementary Partial European Search Report for Application No. 15779232.6, dated Oct. 17, 2017, 14 pages. |
Tice R.R. , “The Single Cell Gel/Comet Assay: A Microgel Electrophoretic Technique for the Detection of DNA Damage and Repair in Individual Cells,” Environmental Mutagenesis, 1995, pp. 315-339. |
U.S. Food and Drug Administration, “Bisphenol A (BPA): Use in Food Contact Application,” 9 pages, [retrieved on Dec. 28, 2017]. Retrieved from the Internet [URL: www.fda.gov/newsevents/publichealthfocus/ucm064437.htm]. |
Vinas P., et al., “Comparison of Two Derivatization-Based Methods for Solid-Phase Microextraction-Gas Chromatography-Mass Spectrometric Determination of Bisphenol A, Bisphenol S and Biphenol Migrated from Food Cans,” Analytical and Bioanalytical Chemistry, Feb. 2010, vol. 397 (1), pp. 115-125. |
Vogel S., “A Non-Estrogenic Alternative to Bisphenol A at Last?,” Environmental Defense Fund, (A blog post dated Jan 23, 2017), 6 pages. |
Woo B.G., et al, “Melt Polycondensation of Bisphenol A Polycarbonate by a Forced Gas Sweeping Process,” Industrial & Engineering Chemistry Research, Feb. 2001, vol. 40 (5), pp. 1312-1319. |
Supplementary European Search Report for EP Application No. 16862969.9 dated Jul. 1, 2019, 7 pages. |
Epoxy Resins, J.S. Massingill, pp. 393-424, Applied Polymer Science: 21st Century, 2000 (the year of publication is sufficiently earlier than the effective U.S. filing date and any foreign priority date so that the particular month of publication is not needed). |
Number | Date | Country | |
---|---|---|---|
20190031816 A1 | Jan 2019 | US |
Number | Date | Country | |
---|---|---|---|
62250217 | Nov 2015 | US |